Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus
- PMID: 28321312
- PMCID: PMC5353273
- DOI: 10.1136/bmjdrc-2016-000352
Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus
Abstract
Objective: Youth onset type 2 diabetes mellitus (YT2DM) is a globally rising phenomenon with substantial Asians representation. The understanding of its pathophysiology is derived largely from studies in the obese African-American and Caucasian populations, while studies on incretin effect are scarce. We examined the insulin resistance, β-cell function (BC), glucagon-like peptide (GLP)-1 hormone and incretin effect in Asian YT2DM.
Research design and methods: This case-control study recruited 25 Asian YT2DM and 15 healthy controls, matched for gender, ethnicity and body mass index. Serum glucose, insulin, C peptide and GLP-1 were sampled during 2-hour oral glucose tolerance tests (OGTTs) and 1-hour intravenous glucose tolerance tests (IVGTTs). Insulin sensitivity was derived from the Quantitative Insulin Sensitivity Check Index (QUICKI), Oral Glucose Insulin Sensitivity Index (OGIS) in OGTT and surrogate index of SI from the minimal model (calculated SI, CSI). Acute insulin response (AIR) was obtained from IVGTT. Total BC was computed as incremental area under the curve of insulin/incremental area under the curve of glucose, during OGTT (BCOG) and IVGTT (BCIV), respectively. Disposition index (DI) was calculated using the product of insulin sensitivity and insulin secretion. GLP-1 response to oral glucose was calculated as incremental area under the curve of GLP-1 (ΔAUCGLP-1). Per cent incretin effect was estimated as 100×(BCOG-BCIV)/BCOG).
Results: The YT2DM had marked impairment in BC (>80% reduction in AIR and BCOG, p<0.001) and lower QUICKI (p<0.001), OGIS (p<0.001) and CSI (p=0.015) compared with controls. There was no difference in GLP-1 at all time points and ΔAUCGLP-1 but the per cent incretin effect was reduced in the YT2DM compared with controls (12.1±8.93 vs 70.0±4.03, p<0.001).
Conclusions: Asian YT2DM showed similar GLP-1 response to oral glucose as controls but reduced incretin effect, BC and insulin sensitivity. The lack of compensatory mechanisms, as shown by the DI may be partly ascribed to the impaired incretin effect, similar to that of adult T2DM.
Trial registration number: NMRR-12-1042-13254.
Keywords: Beta Cell Function; Incretin Physiology; Type 2 Diabetes; Youth.
Conflict of interest statement
Competing interests: None declared.
Figures


Similar articles
-
The incretin effect in critically ill patients: a case-control study.Crit Care. 2015 Nov 16;19:402. doi: 10.1186/s13054-015-1118-z. Crit Care. 2015. PMID: 26567860 Free PMC article.
-
Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.Dan Med J. 2015 Sep;62(9):B4860. Dan Med J. 2015. PMID: 26324089 Clinical Trial.
-
Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.Regul Pept. 2004 Nov 15;122(3):209-17. doi: 10.1016/j.regpep.2004.06.020. Regul Pept. 2004. PMID: 15491793
-
Incretin physiology and pathophysiology from an Asian perspective.J Diabetes Investig. 2015 Sep;6(5):495-507. doi: 10.1111/jdi.12305. Epub 2014 Dec 17. J Diabetes Investig. 2015. PMID: 26417406 Free PMC article. Review.
-
The incretin system and its role in type 2 diabetes mellitus.Mol Cell Endocrinol. 2009 Jan 15;297(1-2):127-36. doi: 10.1016/j.mce.2008.08.012. Epub 2008 Aug 20. Mol Cell Endocrinol. 2009. PMID: 18786605 Review.
Cited by
-
The relationship between glucose and the liver-alpha cell axis - A systematic review.Front Endocrinol (Lausanne). 2023 Jan 5;13:1061682. doi: 10.3389/fendo.2022.1061682. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36686477 Free PMC article.
-
The gut microbiota to the brain axis in the metabolic control.Rev Endocr Metab Disord. 2019 Dec;20(4):427-438. doi: 10.1007/s11154-019-09511-1. Rev Endocr Metab Disord. 2019. PMID: 31656993 Free PMC article. Review.
-
Incretin hormones and type 2 diabetes.Diabetologia. 2023 Oct;66(10):1780-1795. doi: 10.1007/s00125-023-05956-x. Epub 2023 Jul 11. Diabetologia. 2023. PMID: 37430117 Free PMC article. Review.
-
Intestinal Fructose and Glucose Metabolism in Health and Disease.Nutrients. 2019 Dec 29;12(1):94. doi: 10.3390/nu12010094. Nutrients. 2019. PMID: 31905727 Free PMC article. Review.
-
Timosaponin A3 Induces Anti-Obesity and Anti-Diabetic Effects In Vitro and In Vivo.Int J Mol Sci. 2024 Mar 2;25(5):2914. doi: 10.3390/ijms25052914. Int J Mol Sci. 2024. PMID: 38474161 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous